Company intelligence / Profile preview
Yunnan Yongzitang Pharmaceutical Co., Ltd.
- Ownership
- Private
- Employees
- ~250
- Development stage
- Other
Overview
Yunnan Yongzitang Pharmaceutical is a pharmaceutical company specializing in traditional Chinese medicine, with at least one nationally approved product for headache and memory disorders. The company owns several national exclusive TCM patents, reported significant profits as of 2013, and was acquired by Hunan Hansen Pharmaceutical, which now holds an 80% stake. Its lead product is rhizome gastrodiae capsules.
- Therapeutic areas
- Neurology
- Modalities
- Herbal medicineSmall molecules
- Industry
- Biotech
Drug pipeline
10 assets9 more assets in the full pipeline.
Beyond the preview
Go deeper on Yunnan Yongzitang Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Yunnan Yongzitang Pharmaceutical Co., Ltd..